Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
betamethasone + hyaluronic acid
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Intraarticular, Topical
01
Overview
Betamethasone + hyaluronic acid is a combination medication used primarily for intra-articular injections to treat inflammatory joint conditions such as osteoarthritis. Betamethasone is a corticosteroid with anti-inflammatory, immunosuppressive, and antiproliferative properties, while hyaluronic acid provides lubrication and cushioning in joint spaces. This combination is used to reduce pain, inflammation, and improve joint mobility in conditions like knee osteoarthritis. It has also been studied for use in temporomandibular joint disorders and in topical formulations for treating conditions like phimosis.
- Other names
- compound betamethasone + hyaluronic acidcorticosteroids + hyaluronic acidhyaluronic acid and corticosteroids
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on betamethasone + hyaluronic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on betamethasone + hyaluronic acid.